Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Bristol/Myers Squibb Co

Recent news which mentions Bristol/Myers Squibb Co

< Previous 1 2 3 Next >
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
Tags THE JM SMUCKDRN Bristol/Myers Squibb Co stocks
From CNBC.com News
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
Tags Biotechnology Biotech and Pharmaceuticals Breaking News: Business
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Uber Technologies Inc Chipotle Mexican Grill Inc Chevron Corp
From CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
Tags Business Microsoft Corp LILLY DRN
From CNBC.com News
5 things to know before the stock market opens Friday
Tags Business News Economy Meta Platforms Inc
From CNBC.com News
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
Tags Health & Science Pharmaceuticals Bristol/Myers Squibb Co
From CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Tags Health care industry AstraZeneca PLC Health & Science
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Politics Bristol/Myers Squibb Co Pharmaceuticals
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Biotechnology Biotech and Pharmaceuticals Breaking News: Business
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Health care industry Healthy Returns Novartis AG
From CNBC.com News
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
Tags US: News Earnings Pharmaceuticals
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Johnson & Johnson Novo Nordisk A/S Merck & Co Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Ford Motor Co Markets Bristol/Myers Squibb Co
From CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
Tags Bristol/Myers Squibb Co Health & Science Pharmaceuticals
From CNBC.com News
Cramer's Lightning Round: 'I would not abandon' Cava
Tags stocks Bristol/Myers Squibb Co Viking Therapeutics Inc
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Biotech and Pharmaceuticals Pfizer Inc Merck & Co Inc
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Markets Market Outlook Bristol/Myers Squibb Co
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Biotech and Pharmaceuticals Breaking News: Investing Novartis AG
From CNBC.com News
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
Tags Biotechnology Biotech and Pharmaceuticals Business News
From CNBC.com News
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
Tags Earnings Pfizer Inc US: News
From CNBC.com News
5 things to know before the stock market opens Monday
Tags International Business Machines Corp Business Microsoft Corp
From CNBC.com News
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
Tags Health & Science Bristol/Myers Squibb Co Healthy Returns
From CNBC.com News
Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations
Tags Health care industry AstraZeneca PLC Health & Science
From CNBC.com News
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
Tags Companies Business Health care industry
From CNBC.com News
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
Tags Merck & Co Inc US: News Johnson & Johnson
From CNBC.com News
Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch
Tags Technology Health care industry Business
From CNBC.com News
Bristol Myers Squibb results top estimates as new drugs post strong sales growth
Tags Bristol/Myers Squibb Co Health & Science Pharmaceuticals
From CNBC.com News
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
Tags Bristol/Myers Squibb Co Health & Science Health care industry
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Starbucks Corp Qualcomm Inc Technology
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Business News Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.